STEM CELLS Translational Medicine will report on cord blood and perinatal tissue research
Bringing cord blood and tissue research to the health care community is the purpose of a new publishing venture of the Cord Blood Association and AlphaMed Press. STEM CELLS Translational Medicine is now the association’s official scientific journal.
A regular section in the international, peer-reviewed journal will present research articles on umbilical cord blood and tissue-based therapies, engineering and manufacturing of cord blood immune cells, cord blood and tissue banking, and the use of cord blood and cord tissue in regenerative medicine.
Year of Accomplishments Reviewed in CBA President’s Annual Report
At the recent Board of Directors meeting, President Joanne Kurtzberg provided an update on the association’s past year of accomplishments.
Among highlights were an expanded global presence, steps toward a publishing agreement for scientific research, new U.S. legislation benefiting cord blood therapies around the world, participation in medical meetings targeting health professionals in related cell therapy fields, and progress on many other objectives.
The CBA is an international, non-profit organization that promotes both public and family cord blood banking, with the objectives of saving lives, improving health and changing medicine.
Our priorities are advocacy, quality products and services, market expansion, research and development, and public and professional education. If you share these interests, you are cordially invited to join with us.
Expectant parents are faced with important decisions, even before their baby is born. One of the most important is a life-altering decision about whether to bank their baby’s umbilical cord blood, or donate it to help others. If the precious stem cells in cord blood are not banked, they are discarded as medical waste.
There’s no one choice that’s right for all parents. But health care professionals and parents have developed guidelines to help with the decision.